New Innovation Models in Medical AI

48 Pages Posted: 20 Feb 2021 Last revised: 30 Apr 2021

See all articles by W. Nicholson Price II

W. Nicholson Price II

University of Michigan Law School

Rachel Sachs

Washington University in Saint Louis - School of Law

Rebecca S. Eisenberg

University of Michigan Law School

Date Written: February 11, 2021

Abstract

In recent years, scientists and researchers have devoted considerable resources to developing medical artificial intelligence (AI) technologies. Many of these technologies—particularly those which resemble traditional medical devices in their functions—have received substantial attention in the legal and policy literature. But other types of novel AI technologies, such as those that relate to quality improvement and optimizing use of scarce facilities, have been largely absent from the discussion thus far. These AI innovations have the potential to shed light on important aspects of health innovation policy. First, these AI innovations interact less with the legal regimes that scholars traditionally conceive of as shaping medical innovation: patent law, FDA regulation, and health insurance reimbursement. Second, and perhaps related, a different set of innovation stakeholders, including health systems and insurers, are conducting their own research and development in these areas without waiting for commercial product developers to innovate for them. Third and finally, the activities of these innovators have implications for health innovation policy and scholarship. Perhaps most notably, data possession and control play a larger role in determining capacity to innovate in this space, while ability to satisfy the quality standards of regulators and payers plays a smaller role, relative to more familiar biomedical innovations such as new drugs and devices.

Keywords: artificial intelligence, user innovation, intellectual property, FDA law, medical AI

Suggested Citation

Price II, William Nicholson and Sachs, Rachel and Eisenberg, Rebecca S., New Innovation Models in Medical AI (February 11, 2021). Washington University Law Review, Forthcoming, U of Michigan Public Law Research Paper No. 21-009, Available at SSRN: https://ssrn.com/abstract=3783879 or http://dx.doi.org/10.2139/ssrn.3783879

William Nicholson Price II (Contact Author)

University of Michigan Law School ( email )

625 South State Street
Ann Arbor, MI 48109-1215
United States

Rachel Sachs

Washington University in Saint Louis - School of Law ( email )

Campus Box 1120
St. Louis, MO 63130
United States

Rebecca S. Eisenberg

University of Michigan Law School ( email )

625 South State Street
Ann Arbor, MI 48109-1215
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
147
Abstract Views
1,035
rank
237,737
PlumX Metrics